ACB Stock: What’s Behind Aurora Cannabis’ Recent Surge?

More countries are legalizing marijuana. Should you buy ACB stock?

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

The broad market correction brings appealing opportunities for value-cautious investors. Some TSX stocks have corrected by more than 50% while markets, on average, have fallen by around 5% this year.

But not all massively corrected stocks offer value. Some names fall for a reason. Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) stock is one of them. It has fallen 70% this year, terribly underperforming broader markets. However, despite the correction, ACB stock does not look attractive.

What’s next for ACB stock?

ACB stock has shown big movement this week, gaining 20% in the last two trading sessions. The enthusiasm was largely due to its potential expansion in Europe. Besides, bottom-fishing could have also helped the stock trade higher.

Pot stocks saw an epic rally a few years back amidst the hopes of cannabis legalization in the US. Alongside US legalization efforts, Germany has plans to open up its market to these cannabis companies. Germany could be the second-biggest market for these players after the US, which will likely support a higher topline for pot companies.

Aurora Cannabis is among the few companies that have production facilities in Germany. However, it is still too soon and could take years to see a visible impact on its financials.

Cannabis stocks continue to lag broader markets

There has been no respite for Aurora Cannabis investors. The company continues to struggle on the financial front with recurring losses and an unstable topline. Even if the management is confident of turning EBITDA positive soon, management has been guiding that for the last several quarters. EBITDA provides a guage of Aurora’s overall financial performance by focusing on earnings before interest, taxes, depreciation and amortization are accounted for.

Revenues have been on a slow decline for two years, falling 8.6% in Q3 2022 over the year-ago quarter to $50 million. Earnings plummeted 530% for a net loss of over $1 billion. The company has closed several facilities and laid offer some workers in various cost-cutting initiatives this year.

Besides its operational issues, Aurora investors face the rather worrying concern of equity dilution. By consistently increasing total outstanding shares in ACB, Aurora has made existing shareholders’ stakes less valuable.

Aurora Cannabis is a global leader in medical cannabis and earns industry-leading gross margins in the segment. Additionally, it operates in the adult recreational segment, which has seen declining revenue growth of late.

The Foolish takeaway

To turn things around, Aurora must radically increase its revenues. It will also help the company achieve its long-pending target of turning EBITDA positive. Legalization in Germany could drive its revenue growth to some extent.

There seem to be a few positives and many challenges for Aurora Cannabis, which will likely continue to make its path more barbed. It’s not going to be easygoing for ACB investors either, considering the uncertainties and its volatile stock. Even though the stock has come down substantially from its record highs, Aurora Cannabis seems like a high-risk bet.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »